APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Home Parenteral Nutrition (HPN)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Home Parenteral Nutrition (HPN) Market Outlook and Growth Opportunities 2026

Report ID 173998930430 December 2025191 pages

Choose your research edition.

Industry ResearchHome Parenteral Nutrition (HPN) Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Home Parenteral Nutrition (HPN) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Home Parenteral Nutrition (HPN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Home Parenteral Nutrition (HPN) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Home Parenteral Nutrition (HPN) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Home Parenteral Nutrition (HPN) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Home Parenteral Nutrition (HPN) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Home Parenteral Nutrition (HPN) market include B. Braun Melsungen, Grifols International, Otsuka Pharmaceutical, Sichuan Kelun Pharmaceutical, Teva Pharmaceutical, Baxter, Fresenius Kabi, Pfizer and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Home Parenteral Nutrition (HPN) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Home Parenteral Nutrition (HPN) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Home Parenteral Nutrition (HPN) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Parenteral Nutrition (HPN) market size, projected growth trends, production technologies, key applications, and end-use industries.

Home Parenteral Nutrition (HPN) Segment by Company

B. Braun Melsungen

Grifols International

Otsuka Pharmaceutical

Sichuan Kelun Pharmaceutical

Teva Pharmaceutical

Baxter

Fresenius Kabi

Pfizer

Takeda

Home Parenteral Nutrition (HPN) Segment by Type

Parenteral Lipid Emulsion

Single Dose Amino Acid Solution

Carbohydrates

Trace Elements

Vitamins and Minerals

Home Parenteral Nutrition (HPN) Segment by Application

Neonates

Chronic Disease Patients

Geriatrics

Home Parenteral Nutrition (HPN) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Home Parenteral Nutrition (HPN) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Home Parenteral Nutrition (HPN) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Home Parenteral Nutrition (HPN) significant trends, drivers, influence factors in global and regions.

6. To analyze Home Parenteral Nutrition (HPN) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Parenteral Nutrition (HPN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Parenteral Nutrition (HPN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Parenteral Nutrition (HPN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Home Parenteral Nutrition (HPN) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Home Parenteral Nutrition (HPN) industry.

Chapter 3: Detailed analysis of Home Parenteral Nutrition (HPN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Home Parenteral Nutrition (HPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Home Parenteral Nutrition (HPN) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Home Parenteral Nutrition (HPN) Industry Trends Table 2. Home Parenteral Nutrition (HPN) Industry Drivers Table 3. Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges Table 4. Home Parenteral Nutrition (HPN) Industry Restraints Table 5. Global Home Parenteral Nutrition (HPN) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Home Parenteral Nutrition (HPN) Revenue Share by Company (2021-2026) Table 7. Global Home Parenteral Nutrition (HPN) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Company (2021-2026) Table 9. Global Home Parenteral Nutrition (HPN) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Home Parenteral Nutrition (HPN) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Home Parenteral Nutrition (HPN) Key Company Manufacturing Base & Headquarters Table 12. Global Home Parenteral Nutrition (HPN) Company, Product Type & Application Table 13. Global Home Parenteral Nutrition (HPN) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Home Parenteral Nutrition (HPN) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Parenteral Lipid Emulsion Table 18. Significant Companies of Single Dose Amino Acid Solution Table 19. Significant Companies of Carbohydrates Table 20. Significant Companies of Trace Elements Table 21. Significant Companies of Vitamins and Minerals Table 22. Global Home Parenteral Nutrition (HPN) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Type (2021-2026) Table 26. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Type (2027-2032) Table 27. Global Home Parenteral Nutrition (HPN) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Home Parenteral Nutrition (HPN) Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Home Parenteral Nutrition (HPN) Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Home Parenteral Nutrition (HPN) Sales Value Share by Type (2021-2026) Table 31. Global Home Parenteral Nutrition (HPN) Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Neonates Table 33. Significant Companies of Chronic Disease Patients Table 34. Significant Companies of Geriatrics Table 35. Global Home Parenteral Nutrition (HPN) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Application (2021-2026) Table 39. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Application (2027-2032) Table 40. Global Home Parenteral Nutrition (HPN) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Home Parenteral Nutrition (HPN) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Home Parenteral Nutrition (HPN) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Home Parenteral Nutrition (HPN) Sales Value Share by Application (2021-2026) Table 44. Global Home Parenteral Nutrition (HPN) Sales Value Share by Application (2027-2032) Table 45. Global Home Parenteral Nutrition (HPN) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2026) & (K Units) Table 47. Global Home Parenteral Nutrition (HPN) Sales Market Share by Region (2021-2026) Table 48. Global Home Parenteral Nutrition (HPN) Sales by Region (2027-2032) & (K Units) Table 49. Global Home Parenteral Nutrition (HPN) Sales Market Share by Region (2027-2032) Table 50. Global Home Parenteral Nutrition (HPN) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Home Parenteral Nutrition (HPN) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Home Parenteral Nutrition (HPN) Sales Value Share by Region (2021-2026) Table 53. Global Home Parenteral Nutrition (HPN) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Home Parenteral Nutrition (HPN) Sales Value Share by Region (2027-2032) Table 55. Global Home Parenteral Nutrition (HPN) Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Home Parenteral Nutrition (HPN) Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Home Parenteral Nutrition (HPN) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Home Parenteral Nutrition (HPN) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Home Parenteral Nutrition (HPN) Sales by Country (2021-2026) & (K Units) Table 60. Global Home Parenteral Nutrition (HPN) Sales Market Share by Country (2021-2026) Table 61. Global Home Parenteral Nutrition (HPN) Sales by Country (2027-2032) & (K Units) Table 62. Global Home Parenteral Nutrition (HPN) Sales Market Share by Country (2027-2032) Table 63. Global Home Parenteral Nutrition (HPN) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Home Parenteral Nutrition (HPN) Sales Value Market Share by Country (2021-2026) Table 65. Global Home Parenteral Nutrition (HPN) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Home Parenteral Nutrition (HPN) Sales Value Market Share by Country (2027-2032) Table 67. B. Braun Melsungen Company Information Table 68. B. Braun Melsungen Business Overview Table 69. B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio Table 71. B. Braun Melsungen Recent Development Table 72. Grifols International Company Information Table 73. Grifols International Business Overview Table 74. Grifols International Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Grifols International Home Parenteral Nutrition (HPN) Product Portfolio Table 76. Grifols International Recent Development Table 77. Otsuka Pharmaceutical Company Information Table 78. Otsuka Pharmaceutical Business Overview Table 79. Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio Table 81. Otsuka Pharmaceutical Recent Development Table 82. Sichuan Kelun Pharmaceutical Company Information Table 83. Sichuan Kelun Pharmaceutical Business Overview Table 84. Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio Table 86. Sichuan Kelun Pharmaceutical Recent Development Table 87. Teva Pharmaceutical Company Information Table 88. Teva Pharmaceutical Business Overview Table 89. Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio Table 91. Teva Pharmaceutical Recent Development Table 92. Baxter Company Information Table 93. Baxter Business Overview Table 94. Baxter Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Baxter Home Parenteral Nutrition (HPN) Product Portfolio Table 96. Baxter Recent Development Table 97. Fresenius Kabi Company Information Table 98. Fresenius Kabi Business Overview Table 99. Fresenius Kabi Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio Table 101. Fresenius Kabi Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Home Parenteral Nutrition (HPN) Product Portfolio Table 106. Pfizer Recent Development Table 107. Takeda Company Information Table 108. Takeda Business Overview Table 109. Takeda Home Parenteral Nutrition (HPN) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Takeda Home Parenteral Nutrition (HPN) Product Portfolio Table 111. Takeda Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Home Parenteral Nutrition (HPN) Distributors List Table 115. Home Parenteral Nutrition (HPN) Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Home Parenteral Nutrition (HPN) Product Image Figure 2. Global Home Parenteral Nutrition (HPN) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Parenteral Nutrition (HPN) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Home Parenteral Nutrition (HPN) Sales (2021-2032) & (K Units) Figure 5. Global Home Parenteral Nutrition (HPN) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Home Parenteral Nutrition (HPN) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Parenteral Lipid Emulsion Image Figure 10. Single Dose Amino Acid Solution Image Figure 11. Carbohydrates Image Figure 12. Trace Elements Image Figure 13. Vitamins and Minerals Image Figure 14. Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Home Parenteral Nutrition (HPN) Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Type (2021-2032) Figure 17. Global Home Parenteral Nutrition (HPN) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Home Parenteral Nutrition (HPN) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Home Parenteral Nutrition (HPN) Sales Value Share by Type (2021-2032) Figure 20. Neonates Image Figure 21. Chronic Disease Patients Image Figure 22. Geriatrics Image Figure 23. Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Home Parenteral Nutrition (HPN) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Home Parenteral Nutrition (HPN) Sales Volume Share by Application (2021-2032) Figure 26. Global Home Parenteral Nutrition (HPN) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Home Parenteral Nutrition (HPN) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Home Parenteral Nutrition (HPN) Sales Value Share by Application (2021-2032) Figure 29. Global Home Parenteral Nutrition (HPN) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Home Parenteral Nutrition (HPN) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Home Parenteral Nutrition (HPN) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Home Parenteral Nutrition (HPN) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Home Parenteral Nutrition (HPN) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Home Parenteral Nutrition (HPN) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Home Parenteral Nutrition (HPN) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Home Parenteral Nutrition (HPN) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Home Parenteral Nutrition (HPN) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Home Parenteral Nutrition (HPN) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Home Parenteral Nutrition (HPN) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Home Parenteral Nutrition (HPN) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Home Parenteral Nutrition (HPN) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Home Parenteral Nutrition (HPN) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Home Parenteral Nutrition (HPN) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Home Parenteral Nutrition (HPN) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Carbohydrates
  • Trace Elements
  • Vitamins and Minerals
Applications
  • Neonates
  • Chronic Disease Patients
  • Geriatrics
Companies covered
  • B. Braun Melsungen
  • Grifols International
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Teva Pharmaceutical
  • Baxter
  • Fresenius Kabi
  • Pfizer
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Home Parenteral Nutrition (HPN) Sales Value (2021-2032)
  4. 1.2.2 Global Home Parenteral Nutrition (HPN) Sales Volume (2021-2032)
  5. 1.2.3 Global Home Parenteral Nutrition (HPN) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Home Parenteral Nutrition (HPN) Market Dynamics
  1. 2.1 Home Parenteral Nutrition (HPN) Industry Trends
  2. 2.2 Home Parenteral Nutrition (HPN) Industry Drivers
  3. 2.3 Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges
  4. 2.4 Home Parenteral Nutrition (HPN) Industry Restraints
3 Home Parenteral Nutrition (HPN) Market by Company
  1. 3.1 Global Home Parenteral Nutrition (HPN) Company Revenue Ranking in 2025
  2. 3.2 Global Home Parenteral Nutrition (HPN) Revenue by Company (2021-2026)
  3. 3.3 Global Home Parenteral Nutrition (HPN) Sales Volume by Company (2021-2026)
  4. 3.4 Global Home Parenteral Nutrition (HPN) Average Price by Company (2021-2026)
  5. 3.5 Global Home Parenteral Nutrition (HPN) Company Ranking (2024-2026)
  6. 3.6 Global Home Parenteral Nutrition (HPN) Company Manufacturing Base and Headquarters
  7. 3.7 Global Home Parenteral Nutrition (HPN) Company Product Type and Application
  8. 3.8 Global Home Parenteral Nutrition (HPN) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Home Parenteral Nutrition (HPN) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Home Parenteral Nutrition (HPN) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Home Parenteral Nutrition (HPN) Market by Type
  1. 4.1 Home Parenteral Nutrition (HPN) Type Introduction
  2. 4.1.1 Parenteral Lipid Emulsion
  3. 4.1.2 Single Dose Amino Acid Solution
  4. 4.1.3 Carbohydrates
  5. 4.1.4 Trace Elements
  6. 4.1.5 Vitamins and Minerals
  7. 4.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Type
  8. 4.2.1 Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Home Parenteral Nutrition (HPN) Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Home Parenteral Nutrition (HPN) Sales Value by Type
  12. 4.3.1 Global Home Parenteral Nutrition (HPN) Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Home Parenteral Nutrition (HPN) Sales Value by Type (2021-2032)
  14. 4.3.3 Global Home Parenteral Nutrition (HPN) Sales Value Share by Type (2021-2032)
5 Home Parenteral Nutrition (HPN) Market by Application
  1. 5.1 Home Parenteral Nutrition (HPN) Application Introduction
  2. 5.1.1 Neonates
  3. 5.1.2 Chronic Disease Patients
  4. 5.1.3 Geriatrics
  5. 5.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Application
  6. 5.2.1 Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Home Parenteral Nutrition (HPN) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Home Parenteral Nutrition (HPN) Sales Value by Application
  10. 5.3.1 Global Home Parenteral Nutrition (HPN) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Home Parenteral Nutrition (HPN) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Home Parenteral Nutrition (HPN) Sales Value Share by Application (2021-2032)
6 Home Parenteral Nutrition (HPN) Regional Sales and Value Analysis
  1. 6.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2032)
  3. 6.2.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2021-2026
  4. 6.2.2 Global Home Parenteral Nutrition (HPN) Sales by Region (2027-2032)
  5. 6.3 Global Home Parenteral Nutrition (HPN) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Home Parenteral Nutrition (HPN) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Home Parenteral Nutrition (HPN) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Home Parenteral Nutrition (HPN) Sales Value by Region (2027-2032)
  9. 6.5 Global Home Parenteral Nutrition (HPN) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Home Parenteral Nutrition (HPN) Sales Value (2021-2032)
  12. 6.6.2 North America Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Home Parenteral Nutrition (HPN) Sales Value (2021-2032)
  15. 6.7.2 Europe Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Home Parenteral Nutrition (HPN) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Home Parenteral Nutrition (HPN) Sales Value (2021-2032)
  21. 6.9.2 South America Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Home Parenteral Nutrition (HPN) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2025 VS 2032
7 Home Parenteral Nutrition (HPN) Country-level Sales and Value Analysis
  1. 7.1 Global Home Parenteral Nutrition (HPN) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Home Parenteral Nutrition (HPN) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
  4. 7.3.1 Global Home Parenteral Nutrition (HPN) Sales by Country (2021-2026)
  5. 7.3.2 Global Home Parenteral Nutrition (HPN) Sales by Country (2027-2032)
  6. 7.4 Global Home Parenteral Nutrition (HPN) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Home Parenteral Nutrition (HPN) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Home Parenteral Nutrition (HPN) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 B. Braun Melsungen
  2. 8.1.1 B. Braun Melsungen Company Information
  3. 8.1.2 B. Braun Melsungen Business Overview
  4. 8.1.3 B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio
  6. 8.1.5 B. Braun Melsungen Recent Developments
  7. 8.2 Grifols International
  8. 8.2.1 Grifols International Company Information
  9. 8.2.2 Grifols International Business Overview
  10. 8.2.3 Grifols International Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Grifols International Home Parenteral Nutrition (HPN) Product Portfolio
  12. 8.2.5 Grifols International Recent Developments
  13. 8.3 Otsuka Pharmaceutical
  14. 8.3.1 Otsuka Pharmaceutical Company Information
  15. 8.3.2 Otsuka Pharmaceutical Business Overview
  16. 8.3.3 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
  18. 8.3.5 Otsuka Pharmaceutical Recent Developments
  19. 8.4 Sichuan Kelun Pharmaceutical
  20. 8.4.1 Sichuan Kelun Pharmaceutical Company Information
  21. 8.4.2 Sichuan Kelun Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
  24. 8.4.5 Sichuan Kelun Pharmaceutical Recent Developments
  25. 8.5 Teva Pharmaceutical
  26. 8.5.1 Teva Pharmaceutical Company Information
  27. 8.5.2 Teva Pharmaceutical Business Overview
  28. 8.5.3 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
  30. 8.5.5 Teva Pharmaceutical Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Home Parenteral Nutrition (HPN) Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Home Parenteral Nutrition (HPN) Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Takeda
  50. 8.9.1 Takeda Company Information
  51. 8.9.2 Takeda Business Overview
  52. 8.9.3 Takeda Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Home Parenteral Nutrition (HPN) Product Portfolio
  54. 8.9.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Home Parenteral Nutrition (HPN) Value Chain Analysis
  2. 9.1.1 Home Parenteral Nutrition (HPN) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Home Parenteral Nutrition (HPN) Sales Mode & Process
  6. 9.2 Home Parenteral Nutrition (HPN) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Home Parenteral Nutrition (HPN) Distributors
  9. 9.2.3 Home Parenteral Nutrition (HPN) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst